US Stock MarketDetailed Quotes

Sonoma Pharmaceuticals (SNOA)

Watchlist
  • 1.140
  • -0.660-36.67%
Close Apr 24 16:00 ET
  • 1.120
  • -0.020-1.75%
Post 20:01 ET
1.99MMarket Cap-0.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sonoma Pharmaceuticals (SNOA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Total revenue
22.03%4.35M
56.58%5.6M
18.40%4.02M
12.19%14.29M
9.16%3.75M
13.58%3.56M
31.05%3.58M
-1.05%3.39M
-4.05%12.74M
14.10%3.44M
Operating revenue
22.03%4.35M
56.58%5.6M
18.40%4.02M
12.19%14.29M
9.16%3.75M
13.58%3.56M
31.05%3.58M
-1.05%3.39M
-4.05%12.74M
14.10%3.44M
Cost of revenue
17.65%2.7M
57.08%3.48M
22.35%2.55M
10.43%8.82M
-5.20%2.23M
36.71%2.29M
27.40%2.22M
-6.21%2.09M
-9.15%7.99M
9.21%2.35M
Gross profit
29.92%1.65M
55.77%2.12M
12.10%1.46M
15.17%5.47M
40.05%1.53M
-13.01%1.27M
37.47%1.36M
8.47%1.31M
5.99%4.75M
26.27%1.09M
Operating expense
1.17%2.33M
11.13%2.46M
3.23%2.56M
-2.87%9.18M
-12.64%2.18M
-0.13%2.3M
0.59%2.21M
1.43%2.48M
4.41%9.45M
24.32%2.5M
Selling and administrative expenses
-5.50%1.77M
10.38%1.88M
-2.19%1.97M
-2.83%7.36M
-15.21%1.77M
10.04%1.87M
2.59%1.71M
-5.19%2.01M
-14.31%7.58M
15.52%2.09M
Research and development costs
30.44%557K
13.64%575K
26.38%594K
-3.05%1.81M
0.49%411K
-28.95%427K
-5.60%506K
44.62%470K
803.86%1.87M
103.48%409K
Operating profit
34.24%-678K
60.35%-337K
6.65%-1.1M
21.08%-3.71M
53.44%-656K
-22.16%-1.03M
29.64%-850K
5.40%-1.17M
-2.87%-4.7M
-22.84%-1.41M
Net non-operating interest income expense
Other net income (expense)
-341.96%-271K
-201.81%-394K
-183.52%-147K
343.33%803K
156.00%128K
241.77%112K
530.00%387K
183.41%176K
46.25%-330K
117.12%50K
Other non- operating income (expenses)
-341.96%-271K
-201.81%-394K
-183.52%-147K
343.33%803K
156.00%128K
241.77%112K
530.00%387K
183.41%176K
46.25%-330K
117.12%50K
Income before tax
-3.26%-949K
-57.88%-731K
-24.57%-1.24M
42.22%-2.91M
61.15%-528K
0.43%-919K
64.33%-463K
31.29%-997K
2.95%-5.03M
5.56%-1.36M
Income tax
-1,544.44%-130K
-234.01%-197K
-100.68%-1K
380.61%550K
184.93%248K
115.79%9K
-20.97%147K
542.42%146K
-493.94%-196K
-122.90%-292K
Net income
11.75%-819K
12.46%-534K
-8.57%-1.24M
28.50%-3.46M
27.27%-776K
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
Net income continuous Operations
11.75%-819K
12.46%-534K
-8.57%-1.24M
28.50%-3.46M
27.27%-776K
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
Minority interest income
Net income attributable to the parent company
11.75%-819K
12.46%-534K
-8.57%-1.24M
28.50%-3.46M
27.27%-776K
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.75%-819K
12.46%-534K
-8.57%-1.24M
28.50%-3.46M
27.27%-776K
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
Basic earnings per share
23.81%-0.48
45.76%-0.32
43.28%-0.76
73.75%-2.79
71.48%-0.39
60.38%-0.63
89.74%-0.59
76.90%-1.34
65.03%-10.63
75.58%-1.3673
Diluted earnings per share
23.81%-0.48
45.76%-0.32
43.28%-0.76
73.75%-2.79
71.48%-0.39
60.38%-0.63
89.74%-0.59
76.90%-1.34
65.03%-10.63
75.58%-1.3673
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Total revenue 22.03%4.35M56.58%5.6M18.40%4.02M12.19%14.29M9.16%3.75M13.58%3.56M31.05%3.58M-1.05%3.39M-4.05%12.74M14.10%3.44M
Operating revenue 22.03%4.35M56.58%5.6M18.40%4.02M12.19%14.29M9.16%3.75M13.58%3.56M31.05%3.58M-1.05%3.39M-4.05%12.74M14.10%3.44M
Cost of revenue 17.65%2.7M57.08%3.48M22.35%2.55M10.43%8.82M-5.20%2.23M36.71%2.29M27.40%2.22M-6.21%2.09M-9.15%7.99M9.21%2.35M
Gross profit 29.92%1.65M55.77%2.12M12.10%1.46M15.17%5.47M40.05%1.53M-13.01%1.27M37.47%1.36M8.47%1.31M5.99%4.75M26.27%1.09M
Operating expense 1.17%2.33M11.13%2.46M3.23%2.56M-2.87%9.18M-12.64%2.18M-0.13%2.3M0.59%2.21M1.43%2.48M4.41%9.45M24.32%2.5M
Selling and administrative expenses -5.50%1.77M10.38%1.88M-2.19%1.97M-2.83%7.36M-15.21%1.77M10.04%1.87M2.59%1.71M-5.19%2.01M-14.31%7.58M15.52%2.09M
Research and development costs 30.44%557K13.64%575K26.38%594K-3.05%1.81M0.49%411K-28.95%427K-5.60%506K44.62%470K803.86%1.87M103.48%409K
Operating profit 34.24%-678K60.35%-337K6.65%-1.1M21.08%-3.71M53.44%-656K-22.16%-1.03M29.64%-850K5.40%-1.17M-2.87%-4.7M-22.84%-1.41M
Net non-operating interest income expense
Other net income (expense) -341.96%-271K-201.81%-394K-183.52%-147K343.33%803K156.00%128K241.77%112K530.00%387K183.41%176K46.25%-330K117.12%50K
Other non- operating income (expenses) -341.96%-271K-201.81%-394K-183.52%-147K343.33%803K156.00%128K241.77%112K530.00%387K183.41%176K46.25%-330K117.12%50K
Income before tax -3.26%-949K-57.88%-731K-24.57%-1.24M42.22%-2.91M61.15%-528K0.43%-919K64.33%-463K31.29%-997K2.95%-5.03M5.56%-1.36M
Income tax -1,544.44%-130K-234.01%-197K-100.68%-1K380.61%550K184.93%248K115.79%9K-20.97%147K542.42%146K-493.94%-196K-122.90%-292K
Net income 11.75%-819K12.46%-534K-8.57%-1.24M28.50%-3.46M27.27%-776K-7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M
Net income continuous Operations 11.75%-819K12.46%-534K-8.57%-1.24M28.50%-3.46M27.27%-776K-7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M
Minority interest income
Net income attributable to the parent company 11.75%-819K12.46%-534K-8.57%-1.24M28.50%-3.46M27.27%-776K-7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.75%-819K12.46%-534K-8.57%-1.24M28.50%-3.46M27.27%-776K-7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M
Basic earnings per share 23.81%-0.4845.76%-0.3243.28%-0.7673.75%-2.7971.48%-0.3960.38%-0.6389.74%-0.5976.90%-1.3465.03%-10.6375.58%-1.3673
Diluted earnings per share 23.81%-0.4845.76%-0.3243.28%-0.7673.75%-2.7971.48%-0.3960.38%-0.6389.74%-0.5976.90%-1.3465.03%-10.6375.58%-1.3673
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -